Signos Raises $20M for Its FDA-Cleared CGM-Based Weight Management System
Signos, the company behind the first FDA-cleared over-the-counter glucose monitoring system for weight management, has raised $20 million from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. As part of the partnership, Signos will be available for purchase on Stelo.com, Dexcom’s direct-to-consumer CGM site.
Read More from the Global Wellness News ™